semaglutide and cardiac risk Cardiovascular Outcomes in Obesity without Diabetes SELECT Trial

51: 22632270 [DOI] [PubMed] [Google Scholar] 113.Thomsen C, Rasmussen O, Lousen T, et al

Gastrointestinal (digestive tract) side effects are the most common side effects reported with these medications

It analyzes pathway-level variants in FTO, GLP1R, MC4R, and TCF7L2 that may shape baseline GLP-1 and energy-balance biology upstream context that can support a more informed conversation with a qualified provider

If youre pregnant, breastfeeding, severely immunocompromised, or have a central line, avoid live probiotics unless your clinician approves

Our recent work demonstrated that oxidized low-density lipoprotein (LDL) upregulates DPP-4 expression on macrophages via activation of Toll-like receptor 4 (TLR4)/TIR-domain-containing adapter-inducing interferon- (TRIF) and CD36 pathways [36]